Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine bridge to allogeneic HSCT in pediatric advanced myelodysplastic syndrome
ChiCTR2100046337Phase 4Recruiting
- Sponsor
- Children's Hospital of Soochow University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of decitabine in myelodysplastic syndrome (MDS) (6 arms), sponsored by Children's Hospital of Soochow University. Primary endpoints: Remission state, Neutrophil implantation time and 4 more. Started May 2021; status: recruiting.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR2100046337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046337.